絞り込み

17020

広告

「elotuzumab」の検索結果

274件中 101件~120件表示    検索結果をPubMedで見る PubMedで見る

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models.

Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States.

Evaluating Oncology Value-Based Frameworks in the U.S. Marketplace and Challenges in Real-World Application: A Multiple Myeloma Test Case.

Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond.

Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient.

Case Report: Treatment of Light Chain Amyloidosis with Daratumumab Monotherapy in Two Patients.

The effect of novel therapies in high-molecular-risk multiple myeloma.

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update.

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.

[Multiple myeloma : What has been confirmed in therapy?]

A review discussing elotuzumab and its use in the second-line plus treatment of multiple myeloma.

SLAMF7-CAR T-cells eliminate myeloma and confer selective fratricide of SLAMF7(+) normal lymphocytes.

Therapeutic approach for relapsed/refractory multiple myeloma: the logic and practice.

Meta-analysis of the efficacy of treatments for newly diagnosed and relapsed/refractory multiple myeloma with del(17p).

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.

Treatment algorithms for multiple myeloma in Japan.

Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma.

  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. 8
  8. 9
  9. 10
  10. 11
Sort by
※並べ替えは表示に時間がかかります